Expression of Heat Shock Protein-65 by Oligodendrocytes in Vivo and in Vitro: Implications for Multiple Sclerosis
Authors
Affiliations
We studied immunoreactivity for heat shock proteins (HSPs) in multiple sclerosis (MS) brain tissue and detected HSP-65 in chronic MS plaques at the edge of thinly myelinated (or remyelinated) areas. Serial-section immunocytochemistry and double staining revealed that HSP-65+ cells represented reactive, immature oligodendrocytes with strong reactivity for myelin basic protein and weak reactivity for galactocerebroside. Mature oligodendrocytes outside MS plaques did not stain for HSP-65. Control brain sections showed no HSP-65 reactivity. Oligodendrocytes expressed HSP-65 in mixed glial cell cultures. In this system in vitro, oligodendrocytes, but not astrocytes, showed constitutive expression of HSP-65. There was immunoreactivity for HSP-72 in astrocytes in MS and non-MS brains to a similar extent but no association between HSP-72 reactivity and MS plaques. Interestingly, HSP-65+ oligodendrocytes colocalized with T lymphocytes expressing the gamma delta T-cell receptor (TcR). Since HSP-65 has been implicated as a major antigen recognized by TcR gamma delta lymphocytes, our findings might represent a new immunologic interaction within MS plaques that leads to the destruction of immature oligodendrocytes involved in remyelination.
Neuro-Behçet's disease: an update of clinical diagnosis, biomarkers, and immunopathogenesis.
Zhan H, Cheng L, Li Y Clin Exp Immunol. 2025; 219(1).
PMID: 39774671 PMC: 11755846. DOI: 10.1093/cei/uxae123.
γδ T Cells Participating in Nervous Systems: A Story of Jekyll and Hyde.
Li Y, Zhang Y, Zeng X Front Immunol. 2021; 12:656097.
PMID: 33868300 PMC: 8044362. DOI: 10.3389/fimmu.2021.656097.
Hsp70 and its molecular role in nervous system diseases.
Turturici G, Sconzo G, Geraci F Biochem Res Int. 2011; 2011:618127.
PMID: 21403864 PMC: 3049350. DOI: 10.1155/2011/618127.
In vitro and in vivo pharmacological models to assess demyelination and remyelination.
Merrill J Neuropsychopharmacology. 2008; 34(1):55-73.
PMID: 18800062 PMC: 7100020. DOI: 10.1038/npp.2008.145.
White L, Castellano V Sports Med. 2008; 38(3):179-86.
PMID: 18278981 DOI: 10.2165/00007256-200838030-00001.